Paris, France — SENO, an emerging innovator in next-generation nicotine alternatives, successfully showcased its advanced nicotine oral thin film products at a leading international vape and tobacco exhibition in Paris, attracting strong attention from global distributors, retailers, and industry professionals.
 

A Strong Presence at Europe’s Key Industry Event
 

The Paris exhibition, widely recognized as one of the most influential events in the global vaping and nicotine industry, brought together top manufacturers, brands, and buyers from across Europe, the Middle East, and North America.
 

At the event, SENO presented its flagship nicotine oral film series, highlighting its positioning as a smoke-free, discreet, and innovative nicotine delivery solution. Compared with traditional products, SENO’s films offer:
 

Fast absorption and controlled dosage

No combustion, no vapor, and no device required

Portable and user-friendly format

Reduced odor and improved user discretion
 

These features align closely with the growing demand for cleaner and more convenient nicotine alternatives in regulated markets.
 

Innovation Meets Compliance
 

During the exhibition, SENO emphasized its commitment to product safety, compliance, and international standards, which has become a key decision factor for global partners.
 

The company demonstrated its multi-layer safety validation system, including:
 

In vitro cytotoxicity testing based on internationally recognized methods

Third-party laboratory verification

Batch traceability and quality consistency control

Regulatory-oriented product development for EU and US markets

This transparent approach reinforces SENO’s message:

“Not just innovation — but controlled, compliant innovation.”

Expanding Global Distribution Opportunities

SENO’s booth attracted a wide range of potential partners, including:

European distributors seeking compliant alternatives to traditional nicot